D3 logo

D3

Asia, Tokyo, Japan, Tokyo

Description

D3 LLC is providing management consultancy and financial services.

Investor Profile

D3 has made 5 investments, with 4 in the past 12 months and 20% as lead.

Stage Focus

  • Series A (60%)
  • Series B (20%)
  • Seed (20%)

Country Focus

  • United States (60%)
  • Japan (40%)

Industry Focus

  • Pharmaceutical
  • Therapeutics
  • Biotechnology
  • Health Care
  • Medical
  • Drone Management
  • Software
  • Drones
  • Industrial Automation
  • Machinery Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does D3 frequently co-invest with?

SBI Investment
Asia, Chiba, Japan, Minato
Co-Investments: 1
Osaka University Venture Capital
Asia, Osaka, Japan, Osaka
Co-Investments: 1
JGC Holdings Corporation
Asia, Fukushima, Japan, Kanagawa
Co-Investments: 1
Kobe University Capital
Asia, Kyoto, Japan, Kobe
Co-Investments: 1
Eight Roads Ventures Japan
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1

What are some of recent deals done by D3?

Neros Technologies

Los Angeles, California, United States

Neros Technologies is a defense technology company specializing in the development and manufacturing of advanced unmanned aerial systems.

DronesIndustrial AutomationMachinery ManufacturingManufacturing
Series AMar 17, 2025
Amount Raised: $35,000,000
Alpha Fusion

Osaka, Osaka, Japan

Alpha Fusion produces astatine based radiopharmaceuticals for targeted alpha therapy.

MedicalPharmaceuticalTherapeutics
Series BOct 8, 2024
Amount Raised: $6,885,228
Swarmer

Round Rock, Texas, United States

Swarmer is an AI-based mission control center for coordinated drones.

Drone ManagementSoftware
SeedSep 1, 2024
Amount Raised: $2,650,000
RevolKa

Tokyo, Tokyo, Japan

RevolKa is a biotechnology firm that manufactures bio-products pharmaceuticals intended to serve the healthcare sector.

BiotechnologyHealth CarePharmaceutical
Series AAug 29, 2024
Amount Raised: $690,164
Shinobi Therapeutics

South San Francisco, California, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

BiotechnologyHealth CareTherapeutics
Series ADec 12, 2023
Amount Raised: $51,000,000